Company Filing History:
Years Active: 2005
Title: Theodor Bayerköhler: Innovator in Pharmaceutical Engineering
Introduction
Theodor Bayerköhler is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of pharmaceutical engineering, particularly in the development of raw materials for tablet production. With two patents to his name, Bayerköhler's work reflects a dedication to enhancing the efficiency and effectiveness of pharmaceutical formulations.
Latest Patents
Bayerköhler's recent inventions include a "Directly compressible raw material for tablets" and a "Method for producing a tablet made of isomaltulose, isomalt or isomalt variants." The first patent focuses on an improved method for creating agglomerates and compressed products that incorporate isomaltulose and/or hydrogenated isomaltulose. This innovation aims to streamline the production process and improve the quality of the final product. The second patent outlines a method for manufacturing an improved compressed product through the agglomeration of ingredients, resulting in a more efficient tablet production process.
Career Highlights
Theodor Bayerköhler is currently employed at Südzucker Aktiengesellschaft Mannheim/Ochsenfurt, a prominent company in the food and beverage sector. His role there allows him to leverage his expertise in the development of innovative raw materials for various applications, particularly in pharmaceuticals.
Collaborations
Throughout his career, Bayerköhler has collaborated with several talented professionals, including Tillmann Dörr and Jörg Kowalczyk. These collaborations have fostered a productive environment for innovation, allowing for the exchange of ideas and expertise in the field.
Conclusion
Theodor Bayerköhler exemplifies the spirit of innovation within the pharmaceutical engineering sector. With his patents showcasing advancements in tablet production, he continues to contribute significantly to improving the efficacy of pharmaceutical formulations. As he collaborates with industry professionals, his work remains crucial to the ongoing development of efficient and effective pharmaceutical products.